RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price shot up 1.7% during mid-day trading on Tuesday . The stock traded as high as GBX 2.38 and last traded at GBX 2.36. 639,309 shares were traded during trading, a decline of 6% from the average session volume of 683,088 shares. The stock had previously closed at GBX 2.32.
RTW Biotech Opportunities Trading Up 1.3%
The business has a fifty day simple moving average of GBX 2.47 and a 200 day simple moving average of GBX 2.26. The stock has a market cap of £7.71 million, a price-to-earnings ratio of 0.04 and a beta of 0.77. The company has a debt-to-equity ratio of 22.80, a quick ratio of 0.81 and a current ratio of 0.26.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Featured Stories
- Five stocks we like better than RTW Biotech Opportunities
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
